Tuberculosis and HIV: time for an intensified response

@article{Ghebreyesus2010TuberculosisAH,
  title={Tuberculosis and HIV: time for an intensified response},
  author={Tedros Adhanom Ghebreyesus and Michel D. Kazatchkine and Michel Sidib{\'e} and Hiroki Nakatani},
  journal={The Lancet},
  year={2010},
  volume={375},
  pages={1757-1758}
}

Integrating intensified case finding of tuberculosis into HIV care: an evaluation from rural Swaziland

TLDR
ICF was operationally feasible and became established as a routine aspect of tuberculosis and HIV integrated care in Swaziland and was as effective as the hospital service in detecting smear positive TB.

Antiretroviral Treatment in Resource-Limited Settings 2012

TLDR
This special issue examines the current state of HIV care in resource-poor settings and addresses arenas where progress has been slower than anticipated, such as the prevention of mother-to-child HIV transmission and the need for more effective tuberculosis integration and TB treatment campaigns.

HIV testing, antiretroviral therapy, and treatment outcomes in new cases of tuberculosis in Brazil, 2011.

TLDR
The association between ART and treatment success adds to the evidence supporting timely initiation of ART for all patients with TB-HIV coinfection, and creates a convenient baseline for ongoing monitoring of HIV testing, ART use, and TB treatment outcomes among coinfected patients.

Successes and Challenges in an Integrated Tuberculosis/HIV Clinic in a Rural, Resource-Limited Setting: Experiences from Kericho, Kenya

TLDR
An integrated TB/HIV clinic with acceptable outcomes is a feasible goal in resource-limited settings in a rural, Ministry of Health hospital.

Linkage to HIV Care and Antiretroviral Therapy in Cape Town, South Africa

TLDR
Linkage to HIV and ART care was low in this poor periurban community despite free services available within close proximity, and more efforts are needed to link VCT scale-up to subsequent care.

Geographical, health systems’ and sociocultural patterns of tb/hiv co-infected patients’ health seeking behavior in a conflict affected setting : the case of Eastern Democratic Republic of Congo

TLDR
It was found that geographical residence did not play a major role in choice of facility for care by patients infected with TB and HIV, and instead of geographical proximity, availability of drugs and welcoming attitudes determined the choice of integrated care facilities.

Factors associated with patient and health care system delay in diagnosis and treatment for TB in sub‐Saharan African countries with high burdens of TB and HIV

TLDR
Factors causing delayed diagnosis and treatment for tuberculosis in high tuberculosis (TB)/HIV burden African countries are identified.

Outcomes of TB Treatment by HIV Status in National Recording Systems in Brazil, 2003–2008

TLDR
HIV status played an important role in TB treatment outcomes in the study period, and those in the group with unknown HIV status indicate the need for wider HIV testing among new TB cases.

Completeness of tuberculosis reporting forms for disease control in individuals with HIV/AIDS in priority cities of Bahia state.

TLDR
The results showed that despite the completeness of the field HIV be above 50 %, more than half the cases were met as "undone" or "being processed" in all municipalities assessed in the period from 2001 to 2010, suggesting the need for greater availability of HIV testing in these individuals.

An Overview of Tuberculosis-Designated Hospitals in China, 2009-2015: A Longitudinal Analysis of National Survey Data

TLDR
Although China's health reform efforts have resulted in improved TB patient access to quality health care, more attention should be paid to balancing the distribution of medical facilities across different regions to ensure delivery of high-quality laboratory services by TB-designated hospitals throughout China.

References

SHOWING 1-3 OF 3 REFERENCES

WHO's new Stop TB Strategy

Rapid Scale-Up of Antiretroviral Treatment in Ethiopia: Successes and System-Wide Effects

TLDR
The successes and challenges of the scale-up of antiretroviral treatment across Ethiopia are described, including its impact on other health programs and the country's human resources for health.